Kawai T. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11.

Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target Ther. 2021;6:291.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brubaker SW, Bonham KS, Zanoni I, Kagan JC. Innate immune pattern recognition: a cell biological perspective. Annu Rev Immunol. 2015;33:257–90.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Takeuchi O, Akira S. Pattern Recognition Receptors and inflammation. Cell. 2010;140:805–20.

Article  PubMed  CAS  Google Scholar 

Gong T, Liu L, Jiang W, Zhou R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 2020;20:95–112.

Article  PubMed  CAS  Google Scholar 

Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature. 2006;442:39–44.

Article  PubMed  CAS  Google Scholar 

Akira S. Pathogen recognition by innate immunity and its signaling. Proceedings of the Japan Academy Series B, Physical and Biological Sciences. 2009;85:143–56.

Gray EE, Winship D, Snyder JM, Child SJ, Geballe AP, Stetson DB. The AIM2-like receptors are dispensable for the interferon response to intracellular DNA. Immunity. 2016;45:255–66.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Baker B, Zambryski P, Staskawicz B, Dinesh-Kumar SP. Signaling in plant-microbe interactions. Volume 276. New York, NY: Science; 1997. pp. 726–33.

Google Scholar 

Lee MS, Kim Y-J. Signaling pathways downstream of pattern-recognition receptors and their Cross talk. Annu Rev Biochem. 2007;76:447–80.

Article  PubMed  CAS  Google Scholar 

Kanneganti T-D, Lamkanfi M, Núñez G. Intracellular NOD-like receptors in host defense and disease. Immunity. 2007;27:549–59.

Article  PubMed  CAS  Google Scholar 

Steimle V, Otten LA, Zufferey M, Mach B. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell. 1993;75:135–46.

Article  PubMed  CAS  Google Scholar 

Ting JP-Y, Williams KL. The CATERPILLER family: an ancient family of immune/apoptotic proteins. Clin Immunol (Orlando Fla). 2005;115:33–7.

Article  CAS  Google Scholar 

Mótyán JA, Bagossi P, Benkő S, Tőzsér J. A molecular model of the full-length human NOD-like receptor family CARD domain containing 5 (NLRC5) protein. Bmc Bioinf. 2013;14:275.

Article  Google Scholar 

Lee MS, Kim Y-J. Pattern-recognition receptor signaling initiated from extracellular, membrane, and cytoplasmic space. Mol Cells. 2007;23:1–10.

Article  PubMed  CAS  Google Scholar 

Albrecht M, Takken FLW. Update on the domain architectures of NLRs and R proteins. Biochem Biophys Res Commun. 2006;339:459–62.

Article  PubMed  CAS  Google Scholar 

Ting JP-Y, Lovering RC, Alnemri ESPD, Bertin J, Boss JM, Davis B, et al. The NLR gene family: an official nomenclature. Immunity. 2008;28:285–7.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gutte PGM, Jurt S, Grütter MG, Zerbe O. Unusual structural features revealed by the solution NMR structure of the NLRC5 caspase recruitment domain. Biochemistry. 2014;53:3106–17.

Article  PubMed  CAS  Google Scholar 

Yao Y, Qian Y. Expression regulation and function of NLRC5. Protein Cell. 2013;4:168–75.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chang CH, Guerder S, Hong SC, van Ewijk W, Flavell RA. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity. 1996;4:167–78.

Article  PubMed  CAS  Google Scholar 

Yoshihama S, Roszik J, Downs I, Meissner TB, Vijayan S, Chapuy B, et al. NLRC5/MHC class I transactivator is a target for immune evasion in cancer. Proc Natl Acad Sci. 2016;113:5999–6004.

Article  PubMed  PubMed Central  CAS  Google Scholar 

LI X, GUO F, LIU Y, CHEN H-J, WEN F, ZOU B, et al. NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients. Oncol Lett. 2015;10:1533–40.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen Y, Li H, Xiao C, Zeng X, Xiao X, Zhou Q, et al. NLRC5: potential novel non-invasive biomarker for predicting and reflecting the progression of IgA nephritis. J Transl Med. 2018;16:317.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Meissner TB, Li A, Liu Y-J, Gagnon E, Kobayashi KS. The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity. Biochem Biophys Res Commun. 2012;418:786–91.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhu B, Ouda R, An N, Tanaka T, Kobayashi KS. The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation. J Biol Chem. 2024;300:107205.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yao Y, Wang Y, Chen F, Huang Y, Zhu S, Leng Q, et al. NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens. Cell Res. 2012;22:836–47.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kalbasi A, Tariveranmoshabad M, Hakimi K, Kremer S, Campbell KM, Funes JM, et al. Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma. Sci Transl Med. 2020;12:eabb0152.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang P, Yu C, Yu J, Li Z, Lan H, Zhou Q. Arid2-IR promotes NF-kappa B-mediated renal inflammation by targeting NLRC5 transcription. Cell Mol Life Sci. 2021;78:2387–404.

Article  PubMed  CAS  Google Scholar 

Fekete T, Bencze D, Szabo A, Csoma E, Biro T, Bacsi A, et al. Regulatory NLRs control the RLR-mediated type I interferon and inflammatory responses in human dendritic cells. Front Immunol. 2018;9:2314.

Article  PubMed  PubMed Central  Google Scholar 

Zhan L, Zhang J, Wei B, Cao Y. Selective autophagy of NLRC5 promotes immune evasion of endometrial cancer. Autophagy. 2022;18:942–3.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Torkamandi S, Bahrami S, Ghorashi T, Dehani M, Bayat H, Hoseini SM, et al. Dysregulation of long noncoding RNA MEG3 and NLRC5 expressions in patients with relapsing-remitting multiple sclerosis: is there any correlation? Genes Immun. 2021;22:322–6.

Article  PubMed  CAS  Google Scholar 

Georgiev H, Peng C, Huggins MA, Jameson SC, Hogquist KA. Classical MHC expression by DP thymocytes impairs the selection of non-classical MHC restricted innate-like T cells. Nat Commun. 2021;12:2308.

Article  PubMed  PubMe